FindTrial
Sign In

To assess the outcome of Intralesional triamcinolone acetonide with 5 -fluorouracil in the treatment of keloids

A comparative study of intralesional triamcinolone acetonide and triamcinolone acetonide combined with 5-fluorouracil in the treatment of keloids.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049632
Enrollment
50
Registered
2023-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L91- Hypertrophic disorders of skin

Interventions

Intervention1: Intralesional Triamcinolone acetonide vs intralesional triamcinolone acetonide combined with 5-Fluorouracil: Intralesional Triamcinolone acetonide vs intralesional Triamcinolone acetoni

Sponsors

SURYA T
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients with keloids Patients who are willing to participate in the study

Exclusion criteria

Exclusion criteria: Patients below 18 years and above 60 years Pregnancy & Lactation Patient with comorbidities Immunocompromised patients History of previous treatment for keloids and infected ,ulcerated keloids Patients allergic to triamcinolone acetonide , 5-fluorouracil ,and lignocaine Patient not willing to participate in the study

Design outcomes

Primary

MeasureTime frame
PIGMENTATION: 0 - Normal 1 - Hypopigmentation 2 - Mixed 3 - Hyperpigmentation PLIABILITY: 0 - Normal 1 - Supple (flexible with minimal resistance) 2 - Yielding (giving way to pressure) 3 - Firm (inflexible, resistant to manual pressure) 4 - Banding (rope like tissue that blanches) 5 - Contracture (permanent shortening of scar producing deformity) HEIGHT: 0 - Normal 1 - Less than2mm 2 - 2 to 5 mm 3 - more than 5mmTimepoint: every 3 weeks for 18 weeks—

Secondary

MeasureTime frame
Treatment side effectsTimepoint: every 3 weeks for 18 weeks—

Countries

India

Contacts

Public ContactSURYA T

Vinayaka Missions Medical College

Hoddvdvmmckkl@gmail.com09884835199

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026